LCG
MSACU

Luxor Capital Group’s Medicus Sciences Acquisition Corp. Unit MSACU Stock Holding History

Luxor Capital Group’s Portfolio MSACU Stock Details MSACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-32,231
Closed -$318K – 214
2021
Q1 		$318K Buy
+32,231
New +$328K ﹤0.01% 130

Other funds holding MSACU

TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Luxor Capital Group's MSACU Position: Q2 2021 in Review

Luxor Capital Group sold out of Medicus Sciences Acquisition Corp. Unit (MSACU) in Q2 2021, closing a stake of 32,231 shares — an estimated $318K sold.

Luxor Capital Group first reported a position in MSACU in Q1 2021 and held it in 1 quarter. The position peaked at $318K in Q1 2021. 1 fund tracked by Wall St. Rank holds MSACU as of Q2 2021.

  • Luxor Capital Group reported no remaining Medicus Sciences Acquisition Corp. Unit position as of Q2 2021 after selling out during the quarter.
  • Luxor Capital Group sold 32,231 Medicus Sciences Acquisition Corp. Unit shares in Q2 2021, an estimated $318K.
  • Luxor Capital Group first reported a position in Medicus Sciences Acquisition Corp. Unit in Q1 2021 and held it in 1 quarter.
  • Luxor Capital Group's Medicus Sciences Acquisition Corp. Unit position peaked at $318K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Unit as of Q2 2021.

Based on Luxor Capital Group's 13F filing for Q2 2021, filed 17 Aug 2021.